for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

U.S. authorizes lower dose of Regeneron's COVID-19 antibody therapy

June 4 (Reuters) - Regeneron Pharmaceuticals Inc said on Friday the U.S. Food and Drug Administration updated the emergency use authorization for its COVID-19 antibody cocktail, allowing the use of the drug at half the originally authorized dose. (Reporting by Manojna Maddipatla in Bengaluru; Editing by Arun Koyyur)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up